Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 131
Filter
1.
Invest Ophthalmol Vis Sci ; 53(11): 7151-8, 2012 Oct 01.
Article in English | MEDLINE | ID: mdl-22991417

ABSTRACT

PURPOSE: To evaluate the utility and allogenicity of gamma-irradiated corneal allografts. METHODS: Corneal buttons were harvested from C57BL/6 mice and decellularized with gamma irradiation. Cell viability was assessed using TUNEL and viability/cytotoxicity assays. Orthotopic penetrating keratoplasty was performed using irradiated or nonirradiated (freshly excised) C57BL/6 donor grafts and BALB/c or C57BL/6 recipients. Graft opacity was assessed over an 8-week period and graft survival was evaluated using Kaplan-Meier survival curves. Mixed-lymphocyte reactions and delayed-type hypersensitivity assays were performed to evaluate T-cell alloreactivity. Real-time PCR was used to investigate the corneal expression of potentially pathogenic T-helper 1, 2, and 17 cell-associated cytokines. RESULTS: Corneal cells were devitalized by gamma irradiation as evidenced by widespread cellular apoptosis and plasma membrane disruption. Nonirradiated allograft and isograft rates of survival were superior to irradiated allograft and isograft rates of survival (P < 0.001). Mixed lymphocyte reactions demonstrated that T-cells from irradiated allograft recipients did not exhibit a secondary alloimmune response (P < 0.001). Delayed-type hypersensitivity assays demonstrated that irradiated allografts did not elicit an alloreactive delayed-type hypersensitivity response in graft recipients (P ≤ 0.01). The corneal expression of T-helper 1, 2, and 17 cell-associated cytokines was significantly lower in failed irradiated allografts than rejected nonirradiated allografts (P ≤ 0.001). CONCLUSIONS: Gamma-irradiated corneas failed to remain optically clear following murine penetrating keratoplasty; however, gamma irradiation reduced the allogenicity of these corneas, potentially supporting their use in procedures such as anterior lamellar keratoplasty or keratoprosthesis implantation.


Subject(s)
Cornea/immunology , Cornea/radiation effects , Corneal Opacity/etiology , Gamma Rays/therapeutic use , Keratoplasty, Penetrating/methods , Transplantation Immunology/radiation effects , Animals , Cell Survival/immunology , Cell Survival/radiation effects , Corneal Opacity/immunology , Gamma Rays/adverse effects , Graft Rejection/immunology , Graft Rejection/prevention & control , Graft Survival/immunology , Graft Survival/radiation effects , Immunosuppression Therapy/methods , Isoantigens/immunology , Male , Mice , Mice, Inbred BALB C , Mice, Inbred C57BL , T-Lymphocytes, Helper-Inducer/immunology , T-Lymphocytes, Helper-Inducer/radiation effects , Transplantation, Homologous
2.
J Neurosurg ; 107(2): 383-91, 2007 Aug.
Article in English | MEDLINE | ID: mdl-17695394

ABSTRACT

OBJECT: Authors of previous studies have reported that adult transplanted neural progenitor cells (NPCs) are suitable for brain cell replacement or gene delivery. In this study, the authors evaluated survival and integration of adult rat-derived NPCs after transplantation and explored the potential impact on transplant survival of various mechanical and biological factors of clinical importance. METHODS: Adult female Fischer 344 rats were used both as a source and recipient of transplanted NPCs. Both 9L and RG2 rat glioma cells were used to generate in vivo brain tumor models. On the 5th day after tumor implantation, NPCs expressing green fluorescent protein (GFP) were administered either intravenously (3.5 x 10(7) cells) or by stereotactic injection (1 x 10(4)-1 x 10(6) cells) into normal or tumor-bearing brain. The authors evaluated the effect of delivery method (sharp compared with blunt needles, normal compared with zero-volume needles, phosphate-buffered saline compared with medium as vehicle), delivery sites (intravenous compared with intratumoral compared with intraparenchymal), and pretreatment with an immunosuppressive agent (cyclosporin) or brain irradiation (20-40 Gy) on survival and integration of transplanted NPCs. RESULTS: Very few cells survived when less than 10(5) cells were transplanted. When 10(5) cells or more were transplanted, only previously administered brain irradiation significantly affected survival and integration of NPCs. Although GFP-containing NPCs could be readily detected 1 day after injection, few cells survived 4 days to 1 week unless preceded by whole-brain radiation (20 or 40 Gy in a single fraction), which increased the number of GFP-containing NPCs within the tissue more than fivefold. CONCLUSIONS: The authors' findings indicate that most NPCs, including those from a syngeneic autologous source, do not survive at the site of implantation, but that brain irradiation can facilitate subsequent survival in both normal and tumor-bearing brain. An understanding of the mechanisms of this effect could lead to improved survival and clinical utility of transplanted NPCs.


Subject(s)
Brain Neoplasms/therapy , Glioma/therapy , Multipotent Stem Cells/radiation effects , Multipotent Stem Cells/transplantation , Stem Cell Transplantation , Transplantation Immunology/radiation effects , Animals , Brain Neoplasms/immunology , Brain Neoplasms/pathology , Cell Survival/physiology , Cell Survival/radiation effects , Disease Models, Animal , Dose Fractionation, Radiation , Female , Glioma/immunology , Glioma/pathology , Multipotent Stem Cells/physiology , Rats , Rats, Inbred F344 , Stem Cell Transplantation/methods
3.
Exp Hematol ; 31(2): 168-75, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12591282

ABSTRACT

OBJECTIVE: We previously described a nonmyeloablative hematopoietic stem cell transplantation regimen in dog leukocyte antigen (DLA)-identical littermate recipients consisting of low-dose total body irradiation (TBI) before and mycophenolate mofetil (MMF)/cyclosporine (CSP) given after transplant to control both graft-vs-host and residual host-vs-graft reactions. In this study, we sought to develop a reduced-intensity regimen to achieve engraftment across major histocompatibility complex barriers in DLA-haploidentical littermate recipients. MATERIALS AND METHODS: We tested a regimen of 450-cGy TBI with or without postgrafting MMF/CSP for 28 and 35 days, respectively, and with the administration of monoclonal antibody (mAb) S5 (anti-CD44), at a dose of 0.2 mg/kg/day from days -7 through -2, prior to receiving TBI. RESULTS: One of six dogs conditioned with 450-cGy TBI alone achieved engraftment of granulocyte colony-stimulating factor-mobilized peripheral blood stem cells. Three of six dogs achieved sustained donor cell engraftment using 450-cGy TBI and posttransplantation MMF/CSP. None of three dogs given mAb S5 followed by 450-cGy TBI showed signs of donor cell engraftment. However, when S5 mAb pretreatment was added to 450-cGy TBI and postgrafting MMF/CSP, 10 of 12 dogs achieved sustained engraftment (p = 0.008 or 0.007 vs 450-cGy alone or to S5 + 450-cGy TBI without MMF/CSP, respectively), with only three dogs developing severe graft-vs-host disease on this short regimen of immunosuppression. CONCLUSION: These results show that engraftment across a DLA haplotype-mismatched barrier can be achieved after reduced-intensity conditioning when mAb S5 directed at CD44 is added to this regimen.


Subject(s)
Antibodies, Monoclonal/therapeutic use , HLA Antigens/immunology , Hematopoietic Stem Cell Transplantation/methods , Hyaluronan Receptors/immunology , Transplantation Conditioning/methods , Animals , Antibodies, Monoclonal/administration & dosage , Antibodies, Monoclonal/pharmacokinetics , Combined Modality Therapy , Cyclosporine/administration & dosage , Dogs , Graft Survival/drug effects , Graft Survival/radiation effects , HLA Antigens/genetics , Haplotypes/immunology , Models, Animal , Mycophenolic Acid/administration & dosage , Mycophenolic Acid/analogs & derivatives , Transplantation Immunology/drug effects , Transplantation Immunology/radiation effects , Transplantation, Homologous/immunology , Transplantation, Homologous/methods , Treatment Outcome , Whole-Body Irradiation
4.
Blood ; 99(9): 3083-8, 2002 May 01.
Article in English | MEDLINE | ID: mdl-11964269

ABSTRACT

In this study, we investigated the possibility of selective depletion of donor alloantigen-specific T cells from C57BL/6 (H-2(b)) mice to prevent graft-versus-host disease (GVHD). These cells were first activated with irradiated BALB/c (H-2(d)) host spleen cells in a 5-day mixed lymphocyte culture. Following this activation, a photoactive rhodamine derivative called 4,5-dibromorhodamine 123 (TH9402), was added. This compound is selectively retained in the mitochondria of activated host-reactive cells but not tumor- or third-party-specific resting cells. The treated cells were subsequently exposed to visible light (514 nm) to deplete the TH9402-enriched activated host-reactive cells. Treatment with photodynamic cell purging process (PDP) inhibited antihost responses measured by cytotoxic T lymphocytes (CTL) by 93%, and interferon-gamma production by 66%. By contrast, anti-BCL1 (BALB/c-origin leukemia/lymphoma) and anti-third-party C3H/HeJ (H-2(k)) responses were preserved. PDP-treated primed C57BL/6 cells were further tested in vivo. All lethally irradiated BALB/c mice inoculated with BCL1 cells and T-cell-depleted bone marrow cells developed leukemia by day +30, with 50% mortality by 100 days. All mice died of GVHD after addition of 5 x 10(6) untreated primed C57BL/6 cells. However, addition of same numbers of PDP-treated cells allowed 90% of the recipients to survive more than 100 days without detectable BCL1 tumor cells and free of GVHD. Moreover, PDP-treated primed C57BL/6 cells retained the ability to induce GVHD in the third-party C3H/HeJ mice. These data suggest that PDP can selectively deplete host alloantigen-specific T cells for GVHD prevention and immune and antileukemia function preserve.


Subject(s)
Graft vs Host Disease/prevention & control , Lymphocyte Depletion/methods , T-Lymphocytes/radiation effects , Transplantation Immunology/radiation effects , Animals , Bone Marrow Transplantation/methods , Female , Graft vs Leukemia Effect/radiation effects , Histocompatibility/radiation effects , Light , Mice , Mice, Inbred Strains , Photosensitizing Agents/pharmacology , Rhodamines/pharmacology , T-Lymphocytes/immunology , T-Lymphocytes, Cytotoxic/cytology , Tumor Cells, Cultured
5.
Photochem Photobiol ; 62(5): 862-8, 1995 Nov.
Article in English | MEDLINE | ID: mdl-8570724

ABSTRACT

Mice irradiated with UVB, unlike nonirradiated mice, are highly susceptible to syngeneic, immunogenic tumors induced by UVB irradiation or by chemicals. We postulated that UV induced susceptibility to immunogenic tumors results from a reduction in host capacity to generate an interferon (IFN)-gamma immune response to tumor antigens. Shaved BALB/c mice were exposed to 6 x 10(5) J m-2 of UVB radiation delivered intermittently over 12 weeks. The UVB-irradiated and nonirradiated mice received intradermal injections of UVM12 or BP2 tumor cells. After 0, 1.5, 3, 7 or 21 days, draining lymph nodes were excised. Lymph node cells were incubated with UVM12 or BP2 cells that had received 2.5 Gy of gamma-radiation. After 48 h in culture, supernatants were analyzed for IFN-gamma content by enzyme-linked immunosorbent assay and cellular RNA was extracted for mRNA detection by reverse transcriptase-polymerase chain reaction analysis. At 7 days after tumor injection, draining lymph node cells from nonirradiated control mice secreted significant levels of IFN-gamma and contained at least 0.0729 amol of IFN-gamma mRNA/microgram cDNA upon in vitro exposure to gamma-irradiated tumor cells. Draining lymph node cells removed from UV-irradiated mice contained only 18% as much IFN-gamma mRNA and secreted little or no IFN-gamma when exposed to gamma-irradiated tumor cells. A single injection of antibody directed against murine IFN-gamma rendered normal mice as susceptible as UV-irradiated mice to BP2 tumor cells. Thus, chronic UV irradiation leads to an inability of host tumor draining lymph node cells to mount an IFN-gamma response to tumor antigens.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Graft Rejection/prevention & control , Interferon-gamma/biosynthesis , Ultraviolet Rays , Animals , Gene Expression/radiation effects , Graft Rejection/immunology , Interferon-gamma/genetics , Mice , Mice, Inbred BALB C , Mice, Nude , Neoplasm Transplantation , Neoplasms, Experimental/immunology , Photochemistry , Transplantation Immunology/radiation effects
6.
Strahlenther Onkol ; 168(4): 240-3, 1992 Apr.
Article in German | MEDLINE | ID: mdl-1574774

ABSTRACT

The effect of the cellular immune response by total body irradiation was investigated. The transplant survival (skin grafts) was determined as immune parameter. Donors were colony-bred Wistar rats and recipients were colony-bred Sprague-Dawley rats. The investigations were carried out with irradiated rats and with rats irradiated after thymectomy and/or adrenalectomy as well as with animals without irradiation. A single total-body irradiation (1 and 2 Gy) was administered. The skin graft survival in irradiated rats was significant shorter (radiogenic immunostimulation) than in unirradiated rats; there were no significant differences between the operated (thymectomy and/or adrenalectomy) and not operated animals. Including precedent examinations this radiogenic immunostimulation is caused by a relatively selective inactivation of T-suppressor cells.


Subject(s)
Immunity, Cellular/radiation effects , Transplantation Immunology/radiation effects , Whole-Body Irradiation , Adrenalectomy , Animals , Cobalt Radioisotopes , Immunity, Cellular/immunology , Rats , Rats, Inbred Strains , Skin Transplantation/immunology , Thymectomy , Transplantation Immunology/immunology , Transplantation, Homologous
7.
Immunol Today ; 12(4): 119-23, 1991 Apr.
Article in English | MEDLINE | ID: mdl-2059312

ABSTRACT

The interest of immunologists in ultraviolet (UV) irradiation stems from observations made in vitro and in vivo. In vitro, UV irradiation inhibits mitogen and mixed lymphocyte culture (MLC) responses and in vivo, it can induce cutaneous anergy, apparently via suppressor cells and serum factors. At present much interest is focused on the possible use of UV irradiation to permit transfusion without allosensitization and transplantation without either rejection or graft-versus-host disease (GVHD). Here, Derwood Pamphilon and colleagues discuss the current uses and potential of UV irradiation in transfusion and transplantation and relate these to experimental evidence on its effects at the cellular level.


Subject(s)
Immune System/radiation effects , Ultraviolet Rays , Animals , Antigen-Presenting Cells/radiation effects , Antigens, Surface/radiation effects , Blood Platelets/immunology , Blood Platelets/radiation effects , Blood Transfusion , Bone Marrow/immunology , Bone Marrow/radiation effects , Bone Marrow Transplantation/adverse effects , Calcium/metabolism , Cytokines/metabolism , Dogs , Graft vs Host Disease/prevention & control , Humans , Immune Tolerance/radiation effects , Mice , Rats , Secretory Rate/radiation effects , Transplantation Immunology/radiation effects
8.
Clin Orthop Relat Res ; (243): 235-53, 1989 Jun.
Article in English | MEDLINE | ID: mdl-2656027

ABSTRACT

The immune response to osteoarticular allografts is capable of destroying the cartilage--a tissue that has antigens on its cells identical to those on the bone and marrow cells. Osteoarticular allografts of the distal femur were performed in rats using various methods to attempt to temporarily inhibit the antibody response. The temporary systemic immunosuppressant regimens investigated were cyclophosphamide, azathioprine and prednisolone, cyclosporine A, and total lymphoid irradiation. The most successful appeared to be cyclosporine A, but significant side effects were observed. To specifically inhibit the immune response in the allograft antigens without systemically inhibiting the entire immune system, passive enhancement and preadministration of donor blood were tried. Neither was as effective as coating the donor bone with biodegradable cements, a method previously found to be successful. Cyclosporine A was investigated in dogs in a preliminary study of medial compartmental knee allografts and was found to be successful in inhibiting the antibody response and in producing a more successful graft; however, some significant side effects were similarly observed.


Subject(s)
Bone Transplantation , Immunosuppression Therapy/methods , Joints/transplantation , Transplantation Immunology/drug effects , Animals , Antibody Formation/drug effects , Antibody Formation/radiation effects , Blood Transfusion , Cyclophosphamide/pharmacology , Cyclosporins/pharmacology , Dogs , Femur/transplantation , Knee Joint/transplantation , Rats , Rats, Inbred ACI , Rats, Inbred BN , Rats, Inbred Lew , Transplantation Immunology/radiation effects
10.
Z Gesamte Inn Med ; 43(22): 634-8, 1988 Nov 15.
Article in German | MEDLINE | ID: mdl-3064450

ABSTRACT

Sunshine is one of mankind's oldest remedies. Merely forgotten, UV light treatment came back recently due to (1) technological progress, providing particular UV wavelengths (2) basic research, discovering mode of action at molecular level, and (3) rising knowledge about skin as the primary target. Human skin is a rather difficult organ, possessing a considerable part of the immune system, the so-called skin associated lymphoid tissue. Different biological effects are caused by UV irradiation at different wavelengths. UV radiation alone as well as together with a photosensitizer also can cause systemic effects. Dealing with these, results of basic research and their application on modern treatment of some skin diseases, transplantation medicine, non-specific resistance system, and treatment of cardiovascular diseases are discussed.


Subject(s)
Ultraviolet Therapy/methods , Animals , Arterial Occlusive Diseases/radiotherapy , Blood/radiation effects , Humans , Mice , Skin Diseases/radiotherapy , Transplantation Immunology/radiation effects , Whole-Body Irradiation
12.
Transplantation ; 45(5): 845-51, 1988 May.
Article in English | MEDLINE | ID: mdl-3285528

ABSTRACT

Ultraviolet irradiation, particularly in the UVB range, has profound effects on immunological mechanisms. Optimum and tolerable doses of exposure vary from species to species, and from organ to organ. As a result of limited depth penetration and possibly significant energy absorption in nontargeted cells, every model requires diligent determination of an effective nontoxic approach. Nevertheless, it is clear that UVB and UVC irradiation can abolish proliferative and stimulatory ability as well as accessory/antigen-presenting ability of leukocytes in vitro. UV treatment alters cell-surface properties, calcium mobilization, cytokine production and release, and other subcellular processes. Preliminary data suggest that these manipulations also suppress immunity and reduce immunogenicity in vivo. Exposure of solid organs and of large volumes of blood is difficult due to technical problems--in particular poor depth penetration and absorption of UV energy in generally available transfusion bags.


Subject(s)
Transplantation Immunology/radiation effects , Ultraviolet Rays , Animals , Humans , Immunity/radiation effects , Lymphocytes/radiation effects , Skin/immunology , Skin/radiation effects
13.
Biull Eksp Biol Med ; 105(2): 228-31, 1988 Feb.
Article in Russian | MEDLINE | ID: mdl-2894868

ABSTRACT

The protective ability and graft-versus-host (GVH) activity in parental strain hematopoietic fetal liver cells (FLC) transplanted to irradiated F1 hybrids were evaluated quantitatively. A 21-day survival of more than 80% of semi-syngeneic mouse recipients required the injection of 2-5 X 10(6) nucleated fetal liver cells (FLC). The same effect could be obtained with FLC cultivated for 4-15 days. 5 to 25 X 10(6) parental FLC were necessary to induce a considerable GVH mortality within 2-3 months after transplantation. Thus, the minimal cell doses of both native and cultivated FLC enough for the maximal protective effect have proved ineffective for the provocation of the fetal GVH disease. Hematopoietic cells from long-term FLC cultures had a low protective potential though they could contain high CFUs concentration. This discrepancy shows clearly that such polypotent precursors as CFUs have no ability to restore hematopoiesis, in other words they cannot be totipotent stem cells.


Subject(s)
Hematopoietic Stem Cell Transplantation , Liver Transplantation , Animals , Cells, Cultured , Colony-Forming Units Assay , Dose-Response Relationship, Immunologic , Embryo, Mammalian , Female , Graft vs Host Disease/immunology , Graft vs Host Disease/mortality , Hematopoietic Stem Cells/immunology , Liver/immunology , Mice , Mice, Inbred C57BL , Mice, Inbred CBA , Radiation Chimera , Rats , Time Factors , Transplantation Immunology/radiation effects , Transplantation, Isogeneic
14.
Blood ; 69(2): 414-8, 1987 Feb.
Article in English | MEDLINE | ID: mdl-3801661

ABSTRACT

To study the immunosuppressive effects of three different treatments, 30 dogs received at weekly intervals eight platelet transfusions from a single random donor dog. The three experimental protocols were daily oral cyclosporine (Cs) treatment of recipients; in vitro ultraviolet (UV)-irradiation of donor platelets; and Cs-loading of donor platelets. All nine recipients of Cs, 11/12 (92%) recipients of UV-irradiated platelets, and 5/9 (56%) recipients of Cs-loaded donor platelets remained nonimmunized to repeated transfusions of donor platelets. In contrast, only 3 of 21 untreated controls (14%) were not alloimmunized by donor platelets. Moreover, 44% to 67% of the nonimmunized recipients remained tolerant to continued platelet transfusions from their original donor even after experimental therapy was discontinued. Forty-three percent to 100% of transfusions from secondary donors were also accepted without causing alloimmunization, suggesting that tolerance induced by prior treatment was not specific for the primary donor. However, survival of both the original and secondary donor platelets was reduced to about half the starting level, suggesting that some immune response to platelets had occurred. Also, recipients immunized by their original donor's platelets frequently developed refractoriness to platelets from other donors.


Subject(s)
Cyclosporins/pharmacology , Immunosuppression Therapy/methods , Isoantigens/immunology , Platelet Transfusion , Transplantation Immunology , Ultraviolet Rays , Animals , Blood Platelets/drug effects , Blood Platelets/immunology , Blood Platelets/radiation effects , Dogs , Female , Male , Transplantation Immunology/drug effects , Transplantation Immunology/radiation effects
16.
Strahlenther Onkol ; 162(2): 100-4, 1986 Feb.
Article in English | MEDLINE | ID: mdl-3513354

ABSTRACT

By means of national survey, records of 78 acute leukemia patients who underwent allogeneic bone marrow transplantation (BMT) from September 1975 through September 1983 were collected from 14 participating institutions in Total Body Irradiation (TBI) Subcommittee in Japan. Patients were classified into 37 of acute lymphocytic leukemia (ALL), and 41 of acute non-lymphocytic leukemia (ANLL). One-year survivals were 51% and 33% in ALL and ANLL patients, respectively. Uninfected patients in remission had significantly better survival than infected ones and/or in relapse. Overall incidence of interstitial pneumonia was 43%. Rejection and relapse were encountered in 26% of patients. Concerning cause of death, interstitial pneumonia was the most frequent cause (44%). Uni- and multivariate analyses strongly suggested that favorable prognostic factors were remission, uninfection, preparation of low-dose-rate fractionated TBI and cyclophosphamide, and mild graft-versus-host disease (GVHD) for acute leukemia patient treated with allogeneic BMT.


Subject(s)
Bone Marrow Transplantation , Leukemia/therapy , Transplantation Immunology/radiation effects , Whole-Body Irradiation , Acute Disease , Adolescent , Adult , Child , Female , Humans , Male , Middle Aged , Prognosis , Pulmonary Fibrosis/etiology , Retrospective Studies , Whole-Body Irradiation/adverse effects
17.
Am J Reprod Immunol Microbiol ; 10(2): 35-8, 1986 Feb.
Article in English | MEDLINE | ID: mdl-3963297

ABSTRACT

Seven-day-old embryos of several H-2 congenic strains were transplanted under the kidney capsules of syngeneic adult recipients to determine the genetic factors(s) governing the in vivo growth of embryo-derived teratomas. A.TH(H-2t2) and A.TL(H-2t1) strains showed significantly greater tumor weights than A.BY(H-2b) and A.SW(H-2s) strains. The A(H-2a) strain was intermediate in tumor size. A comparison of the genic constitution of the H-2 complex in each congenic strain suggested that the H-2D locus and/or its distal regions affected the growth of embryo-derived teratomas. The teratoma induced in the B10.A(H-2a) strain was smaller than that in the A(H-2a) strain, indicating that the genetic background of the A strain is favorable for teratoma growth. Histological observations demonstrated that the existence of embryonal carcinoma cells was necessary for the growth of teratomas. A radiation-sensitive immunological factor in the recipient probably plays a role in stimulating teratoma growth.


Subject(s)
H-2 Antigens/immunology , Teratoma/immunology , Animals , Embryo, Mammalian/immunology , Female , H-2 Antigens/genetics , Male , Mice , Mice, Inbred A , Neoplasm Transplantation , Pregnancy , Radiation Tolerance , Species Specificity , Transplantation Immunology/radiation effects , Transplantation, Isogeneic
20.
Int J Radiat Oncol Biol Phys ; 11(7): 1285-91, 1985 Jul.
Article in English | MEDLINE | ID: mdl-3891697

ABSTRACT

A total of 22 patients with leukemia (10 ALL, 11 AML, 1 CML) have undergone allogeneic bone marrow transplantation (BMT) by the Quebec Co-operative Group for Marrow Transplantation from 1980 to 1982. All patients received 900 cGy total body irradiation (TBI), in a single fraction, on the day preceding BMT. The first 11 patients were treated on a cobalt unit at a constant dose rate of 4.7 to 6.3 cGy/min. Six of these patients developed interstitial pneumonitis (IP). The clinical course of three patients, two with idiopathic and one with drug-induced pneumonitis, was mild and recovery was complete in all. The other three patients developed severe infectious IP and two died. The next 11 patients were treated with a sweeping beam technique on a 4 MV linear accelerator delivering a total tumor dose of 900 cGy at an average dose rate of 6.0 to 6.5 cGy/min but an instantaneous dose rate of 21.0 to 23.5 cGy/min. Eight patients developed severe IP. Five of these were idiopathic and four died. Three were infectious and all died. The fatality of interstitial pneumonitis appeared to be greater in the group treated with the sweeping beam technique.


Subject(s)
Bone Marrow Transplantation , Leukemia/therapy , Pulmonary Fibrosis/etiology , Transplantation Immunology/radiation effects , Whole-Body Irradiation/adverse effects , Adolescent , Adult , Female , Humans , Male , Whole-Body Irradiation/methods
SELECTION OF CITATIONS
SEARCH DETAIL
...